Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CAPR

CAPRICOR THERAPEUTICS (CAPR) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $7.83 -2.2% on the day +2.8% over 12 months 52-week range $3.85 – $35.34

Share price and insider trades

CAPR closeInsider buyInsider sale
010203040NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $24,000 on 2026-06-24 · Anthony Bergmann, Karen KrasneySold $30,000 on 2026-06-22 · Anthony Bergmann, Karen KrasneySold $240,928 on 2026-04-02 · Karimah Es SabarSold $1,464,316 on 2026-06-25 · Anthony Bergmann, Karen KrasneySold $1,585,000 on 2026-05-01 · Anthony Bergmann, Karen KrasneySold $1,667,397 on 2026-04-01 · Karimah Es SabarSold $3,354,615 on 2026-03-31 · Anthony Bergmann, Karen Krasney, Karimah Es Sabar
Bought, 12 months$0
Sold, 12 months$8.4M
Insiders buying0
Insiders selling3

CAPRICOR THERAPEUTICS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $8.4M of CAPR stock on the open market.

CAPR insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $3.4M sold (3 trades)Q1 2026Q2 2026: $5.0M sold (10 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$5.0M10
Q1 2026—0$3.4M3

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.4×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 CAPRICOR THERAPEUTICS, INC. insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $8.4M. 13 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 29SEC Anthony BergmannCFO Sell Plan 24,10011,223 held (−68%) $30.38 $732K -74.2% —
Jun 29SEC Karen KrasneyGeneral Counsel Sell Plan 24,10030,547 held (−44%) $30.38 $732K -74.2% —
Jun 24SEC Anthony BergmannCFO Sell Plan 50011,223 held (−4%) $30.00 $15K -73.9% —
Jun 24SEC Karen KrasneyGeneral Counsel Sell Plan 50030,547 held (−2%) $30.00 $15K -73.9% —
Jun 24SEC Anthony BergmannCFO Sell Plan 40011,223 held (−3%) $30.00 $12K -73.9% —
Jun 24SEC Karen KrasneyGeneral Counsel Sell Plan 40030,547 held (−1%) $30.00 $12K -73.9% —
May 4SEC Anthony BergmannCFO Sell Plan 25,0008,223 held (−75%) $31.70 $792K -75.3% —
May 4SEC Karen KrasneyGeneral Counsel Sell Plan 25,00030,547 held (−45%) $31.70 $792K -75.3% —
Apr 3SEC Karimah Es SabarDirector Sell Plan 7,529 $32.00 $241K -75.5% —
Apr 1SEC Karimah Es SabarDirector Sell Plan 61,265 $30.17 $1.8M -74.0% —
Apr 1SEC Karimah Es SabarDirector Sell Plan 53,735 $31.03 $1.7M -74.8% —
Apr 1SEC Anthony BergmannCFO Sell Plan 25,0008,223 held (−75%) $30.13 $753K -74.0% —
Apr 1SEC Karen KrasneyGeneral Counsel Sell Plan 25,00030,547 held (−45%) $30.12 $753K -74.0% —

Insiders at CAPRICOR THERAPEUTICS, INC.

InsiderBoughtSoldLast filingScore
Karimah Es SabarDirector — $3.8M Apr 3, 2026 —
Anthony BergmannCFO — $2.3M Jun 29, 2026 —
Karen KrasneyGeneral Counsel — $2.3M Jun 29, 2026 —

CAPR stock: common questions

Are CAPRICOR THERAPEUTICS, INC. insiders buying CAPR stock?

In the past 12 months, 0 insiders reported open-market purchases of CAPR worth $0.

Are CAPRICOR THERAPEUTICS, INC. insiders selling CAPR stock?

3 insiders reported sales worth $8.4M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CAPR's 52-week range?

Over the past year CAPR has traded between $3.85 and $35.34. It last closed at $7.83 on Oct 9, 2026.